[Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].

Autor: Ruzhentsova TA; FSBI Gabrichevsky research institute for epidemiology and microbiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)., Khavkina DA; FSBI Central Research Institute for Epidemiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)., Chukhliaev PV; FSBI Central Research Institute for Epidemiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)., Garbuzov AA; FSBI Central Research Institute for Epidemiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)., Ploskireva AA; FSBI Central Research Institute for Epidemiology of the Surveillance of Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor).

Publikováno v: Voprosy virusologii [Vopr Virusol] 2021 Mar 07; Vol. 66 (1), pp. 40-46. Date of Electronic Publication: 2021 Mar 07.